US: SEC Subpoenas Biotech-Turned-Crypto Company Riot Blockchain
Cointelegraph
Published Apr 18, 2018 08:57AM ET
Updated Apr 18, 2018 10:32AM ET
US: SEC Subpoenas Biotech-Turned-Crypto Company Riot Blockchain
Riot Blockchain, one of the many companies that changed their name to contain the word 'Blockchain' last year evidently on industry hype, has received a subpoena from the US Securities and Exchange Commission (SEC), according to a SEC Form 10-K annual report filed Tuesday, April 17.
The filing writes that Riot Blockchain received a SEC subpoena on April 9 containing a request for “certain information” from the company, adding that they intend to “fully cooperate” with the request. Riot Blockchain makes clear that they are not particularly concerned with the move as “many companies engaged in blockchain and cryptocurrency businesses have received subpoenas from the SEC,” evidently in reference to the SEC’s publicized crypto probe.
Continue Reading on Cointelegraph
Get The News You Want
Written By: Cointelegraph
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.